Access cutting-edge prostate cancer treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.
Access prostate cancer specialists in Boston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related prostate cancer treatment provided free
This study is testing the way that approved androgen deprivation therapy treatments, Leuprolide and Relugolix, for prostate cancer affect quality of life, blood levels, cholesterol, and blood sugar. The drugs are already standard treatment for people with prostate cancer, and the drugs will be used as described in their label. The names of the study drugs involved in this study are: * Leuprolide (type of ADT) * Relugolix (type of ADT)
Sponsor: Dana-Farber Cancer Institute
Check if you qualify for this prostate cancer clinical trial in Boston, MA
If you're searching for prostate cancer treatment options in Boston, MA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced prostate cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.